FRANK E. MOTT to Mutation
This is a "connection" page, showing publications FRANK E. MOTT has written about Mutation.
Connection Strength
0.050
-
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. J Clin Oncol. 2022 03 01; 40(7):702-709.
Score: 0.050